Form 4: Entera Bio CEO Receives Stock Options and Restricted Stock Units Following Shareholder Approval
SEC Form 4 Filing
Entera Bio's CEO, Miranda Jayne Toledano, reports the acquisition of stock options and restricted stock units after shareholder approval on July 31, 2024.
Summary
- Miranda Jayne Toledano, CEO of Entera Bio Ltd., filed a Form 4 on August 2, 2024, reporting changes in beneficial ownership.
- The report details the acquisition of 124,121 ordinary shares through stock-settled restricted stock units granted at $0.00 per share.
- These restricted stock units were approved by the Board on April 19, 2024, and by shareholders on July 31, 2024.
- The restricted stock units vest ratably on a quarterly basis over one year, starting April 19, 2024.
- Toledano also acquired options to purchase 500,000 ordinary shares at an exercise price of $1.99.
- These options were also approved by the Board on April 19, 2024, and by shareholders on July 31, 2024.
- The options vest over a three-year period commencing April 19, 2024, with one-third vesting on the first anniversary and the remainder vesting quarterly over the subsequent two years.
- Following these transactions, Toledano directly owns 234,873 ordinary shares and 500,000 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices. The grants align management interests with shareholders, which is generally viewed favorably.
Positives
- The grant of stock options and restricted stock units to the CEO aligns her interests with those of the shareholders.
- The vesting schedules for both the restricted stock units and options incentivize long-term performance and commitment from the CEO.
Industry Context
Stock option and RSU grants are common practice to incentivize and retain key executives in publicly traded companies, particularly in the biotech industry.
Stakeholder Impact
- Shareholders may view the grants positively as they incentivize the CEO to increase shareholder value.
- Employees may see the grants as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 04/19/2024 | Board of Directors approved the grant of stock-settled restricted stock units and options. |
| 07/31/2024 | Shareholders approved the grant of stock-settled restricted stock units and options. |
| 07/31/2024 | Date of transaction for the acquisition of ordinary shares and stock options. |
| 08/02/2024 | Date of Form 4 filing. |
| 04/19/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.